Overview

Detection and Enumeration of Circulating Tumor Cells in Rectal Cancer

Status:
Unknown status
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
Rectal cancer is one of the most common malignant tumors in the world. However, there's also no reliable and sensitive method to monitor diseases and evaluate therapy responses till now. Circulating tumor cells, which could reflect tumor's status correctly and reliably, may be a promising method in this field. This study is to investigate the role of circulating tumor cells in evaluating and predicting the responses of chemoradiotherapy in rectal cancer.
Details
Lead Sponsor:
Fudan University
Treatments:
Capecitabine
Oxaliplatin